Work

Toward personalized therapy in AML: in vivo benefit of targeting aberrant epigenetics in MLL-PTD-associated AML

Year: 2013

Type: article

Source: Leukemia

DOI: 10.1038/leu.2013.147

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Nationwide Children's Hospital

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Ohio State University, National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences

Awards: G1187269241, G1438232664, Experimental Therapeutics of Leukemia, G265530323, G3710688305, G4211022069, Pharmacological modulation of epigenetic changes in AML, G7047605171, G7338240445, G892240875, Cancer Center Support Grant

OpenAlex ID: W2013419259

FWCI: 1.487

Cites: 15

Cited by: 13

Related to: 10